For those with osteoarthritis, inflammation is a serious issue and can contribute to cartilage loss, joint pain, swelling and stiffness.
At the Helen Foundation, we have studied the effects of inflammation on the body for years and have developed an effective solution to reduce inflammation of osteoarthritis.
Through hydrocortisone microdosing, those battling moderate to severe osteoarthritis saw an average 77% symptom improvement in our extensive study. By comparison, Celebrex averages 25% symptom improvement in the treatment of osteoarthritis.
This high rate of success comes from our microdosing techniques that ask patients to only take hydrocortisone on the bad days of their inflammation, and not on the good ones.
Hydrocortisone is produced naturally in the body to reduce inflammation, but this production can dip as we age. When administered properly, a hydrocortisone microdose will increase hydrocortisone in the body up to the required levels to arrest inflammation with no side effects.
Should you feel that microdose therapy for osteoarthritis is right for you, and you would like to learn more, we are standing by to help you gain a better understanding of these techniques.
As you begin your microdosing journey our team will measure your osteoarthritis’ severity daily, offer prescriptions from doctors by telemedicine and provide an easy-to-understand Patient Education Manual.
Give us a call today at 812-TO-HELEN (812-864-3536) with any questions you may have and be sure to consult your primary doctor so they can participate in these treatments.